The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

Friday, February 08, 2013

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference18:45 EST Friday, February 08, 2013BOULDER, Colo., Feb. 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.    (Logo: Event:             Leerink Swann Healthcare Conference Presenter:          Ron Squarer, Chief Executive OfficerDate:                      Thursday, February 14, 2013Time:                  8:00 a.m. Eastern Time Location:                The Waldorf Astoria, New York, NYWebcast:                www.arraybiopharma.comAbout Array BioPharmaArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. During 2013, Array expects to make substantial progress in generating data to inform registration study decisions for our wholly-owned hematology programs, ARRY-520 and ARRY-614.  Array-invented MEK162 will be tested in a Phase 3 trial in NRAS melanoma which is scheduled to start in April 2013, as well as BRAF mutant melanoma later in 2013 (with Novartis). Also, AstraZeneca recently announced a potential start of a Phase 3 trial with Array-invented selumetinib in non-small cell lung cancer during the second half of 2013.   For more information on Array, please go to  Tricia HaugetoArray BioPharma Inc.303-386-1193thaugeto@arraybiopharma.comSOURCE Array BioPharma Inc.